Virtus ETF Advisers’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-8,166
| Closed | -$340K | – | 514 |
|
|
2024
Q4 | $340K | Buy |
8,166
+5,898
| +260% | +$245K | 0.14% | 218 |
|
|
2024
Q3 | $152K | Hold |
2,268
| – | – | 0.07% | 324 |
|
|
2024
Q2 | $269K | Sell |
2,268
-2,169
| -49% | -$258K | 0.13% | 241 |
|
|
2024
Q1 | $473K | Buy |
4,437
+638
| +17% | +$68K | 0.25% | 182 |
|
|
2023
Q4 | $378K | Buy |
3,799
+1,385
| +57% | +$138K | 0.24% | 175 |
|
|
2023
Q3 | $249K | Sell |
2,414
-5,795
| -71% | -$599K | 0.15% | 226 |
|
|
2023
Q2 | $997K | Buy |
8,209
+6,737
| +458% | +$819K | 0.59% | 12 |
|
|
2023
Q1 | $226K | Buy |
1,472
+24
| +2% | +$3.69K | 0.12% | 298 |
|
|
2022
Q4 | $260K | Sell |
1,448
-492
| -25% | -$88.4K | 0.14% | 301 |
|
|
2022
Q3 | $229K | Sell |
1,940
-5,173
| -73% | -$611K | 0.09% | 304 |
|
|
2022
Q2 | $1.02M | Buy |
7,113
+5,771
| +430% | +$824K | 0.38% | 87 |
|
|
2022
Q1 | $231K | Hold |
1,342
| – | – | 0.1% | 188 |
|
|
2021
Q4 | $341K | Sell |
1,342
-866
| -39% | -$220K | 0.13% | 184 |
|
|
2021
Q3 | $850K | Sell |
2,208
-199
| -8% | -$76.6K | 0.37% | 95 |
|
|
2021
Q2 | $566K | Sell |
2,407
-1,624
| -40% | -$382K | 0.23% | 120 |
|
|
2021
Q1 | $528K | Buy |
4,031
+106
| +3% | +$13.9K | 0.22% | 141 |
|
|
2020
Q4 | $410K | Sell |
3,925
-1,049
| -21% | -$110K | 0.17% | 152 |
|
|
2020
Q3 | $352K | Sell |
4,974
-686
| -12% | -$48.5K | 0.18% | 187 |
|
|
2020
Q2 | $363K | Sell |
5,660
-13,644
| -71% | -$875K | 0.17% | 249 |
|
|
2020
Q1 | $578K | Sell |
19,304
-2,829
| -13% | -$84.7K | 0.24% | 157 |
|
|
2019
Q4 | $433K | Buy |
22,133
+5,736
| +35% | +$112K | 0.07% | 231 |
|
|
2019
Q3 | $261K | Sell |
16,397
-914
| -5% | -$14.5K | 0.05% | 212 |
|
|
2019
Q2 | $253K | Buy |
+17,311
| New | +$253K | 0.05% | 273 |
|